{"id":36701,"date":"2015-09-08T08:36:18","date_gmt":"2015-09-08T12:36:18","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36701"},"modified":"2015-09-08T08:36:18","modified_gmt":"2015-09-08T12:36:18","slug":"can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701","title":{"rendered":"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart?"},"content":{"rendered":"<p style=\"text-align: justify;\">In last trading session, the stock price of <strong>Pharmacyte Biotech Inc (OTCMKTS:PMCB) <\/strong>declined 0.52% to close the week at $0.0959. The decline came at a share volume of 1.06 million compared to monthly average share volume of 1.52 million. Pharmacyte stock has been stuck in a low trading session from last few trading sessions.<\/p>\n<p style=\"text-align: justify;\">Recently, the company\u2019s CEO Mr. Kenneth L. Waggoner, JD interview got published in PharmaVOICE wherein it <a href=\"http:\/\/finance.yahoo.com\/q;_ylt=AkynTmYw_HUiicPyalZfdQMnv7gF?uhb=uhb2&amp;fr=uh3_finance_vert_gs&amp;type=2button&amp;s=PMCB%2C\">stated<\/a> that company will take expert advice of the three known physicians in oncology. The team of three experts will guide them in advancing planned clinical studies to treat advanced pancreatic cancer and further contribute in the planning of future studies.<\/p>\n<p style=\"text-align: justify;\"><strong>Uluru Inc (OTCMKTS:ULUR) Updates On Quarterly Performance <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Uluru Inc (OTCMKTS:ULUR)<\/strong> <a href=\"http:\/\/www.prnewswire.com\/news-releases\/uluru-inc-reports-second-quarter-2015-financial-results-300128953.html\">reported<\/a> a net loss of $729,000 in the second quarter of fiscal versus a net loss of $710,000 in the comparable period in 2014. For the first six months completed June 30, the net loss amounted to $1.47 million versus a net loss of $1.58 million in 2Q2014.<\/p>\n<p style=\"text-align: justify;\">In the reported quarter, the company reported positive interim report of the pharmaco-economic assessment process being done in Europe. Also, Uluru obtained marketing consent in Russia to kick off sales of Altrazeal\u00ae. In 2Q2015, the company successfully closed the first order of Altrazeal\u00ae for Egypt and partially completed the order of Saudi Arabia. Kerry P. Gray, the CEO stated that company\u2019s geographic expansion is moving as planned and with more approvals, they anticipate increased product launches in various regions including Europe and Russia.<\/p>\n<p style=\"text-align: justify;\">In last trading session, the stock price of ULUR jumped more than 3% to close the week at $0.340.<\/p>\n<p style=\"text-align: justify;\"><strong>DARA Biosciences Inc (NASDAQ:DARA) Trades In Narrow Range<\/strong><\/p>\n<p style=\"text-align: justify;\">In last trading session, the stock price of <strong>DARA Biosciences Inc (NASDAQ:DARA)<\/strong> gained 0.98% and closed at $0.823. The Pharma company <a href=\"http:\/\/www.marketwatch.com\/story\/dara-biosciences-to-present-at-the-17th-annual-rodman-and-renshaw-global-investment-conference-on-september-9-2015-2015-09-02-161733013\">disclosed<\/a> that it will be participate in the \u201cRodman and Renshaw Global Investment Conference\u201d to be held this week.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In last trading session, the stock price of Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% to close the week at $0.0959. The decline came at a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":26999,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[11680,4733,4734,11643,11679,11642,11641,11678,11677],"stock_ticker":[],"class_list":["post-36701","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-dara-biosciences-inc","tag-dara-biosciences-inc-nasdaqdara","tag-nasdaqdara","tag-otcmktspmcb","tag-otcmktsulur","tag-pharmacyte-biotech-inc","tag-pharmacyte-biotech-inc-otcmktspmcb","tag-uluru-inc","tag-uluru-inc-otcmktsulur","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart? - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart? - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"In last trading session, the stock price of Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% to close the week at $0.0959. The decline came at a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-08T12:36:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"216\" \/>\n\t<meta property=\"og:image:height\" content=\"234\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart?\",\"datePublished\":\"2015-09-08T12:36:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701\"},\"wordCount\":323,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\",\"keywords\":[\"DARA Biosciences Inc\",\"DARA Biosciences Inc (NASDAQ:DARA)\",\"NASDAQ:DARA\",\"OTCMKTS:PMCB\",\"OTCMKTS:ULUR\",\"Pharmacyte Biotech Inc\",\"Pharmacyte Biotech Inc (OTCMKTS:PMCB)\",\"Uluru Inc\",\"Uluru Inc (OTCMKTS:ULUR)\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701\",\"name\":\"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart? - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\",\"datePublished\":\"2015-09-08T12:36:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\",\"width\":216,\"height\":234},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart? - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701","og_locale":"en_US","og_type":"article","og_title":"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart? - Wall Street PR","og_description":"In last trading session, the stock price of Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% to close the week at $0.0959. The decline came at a [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-09-08T12:36:18+00:00","og_image":[{"width":216,"height":234,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart?","datePublished":"2015-09-08T12:36:18+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701"},"wordCount":323,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","keywords":["DARA Biosciences Inc","DARA Biosciences Inc (NASDAQ:DARA)","NASDAQ:DARA","OTCMKTS:PMCB","OTCMKTS:ULUR","Pharmacyte Biotech Inc","Pharmacyte Biotech Inc (OTCMKTS:PMCB)","Uluru Inc","Uluru Inc (OTCMKTS:ULUR)"],"articleSection":["Business","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701","url":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701","name":"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart? - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","datePublished":"2015-09-08T12:36:18+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","width":216,"height":234},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/can-pharmacyte-biotech-inc-otcmktspmcb-move-up-on-the-chart-36701#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart?"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36701"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36701\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/26999"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36701"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}